Wolverine Trading, LLC Nevro Corp Put Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $24,492 - $52,520	5,200 Added 6.8%	81,700 $455,000
Q2 2024 Aug 14, 2024	BUY	$7.96 - $13.59 $428,248 - $731,142	53,800 Added 237.0%	76,500 $644,000
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $307,812 - $471,706	22,700 New	22,700 $327,000
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $2 Million - $3 Million	-24,700 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$101.99 - $166.36 $1.78 Million - $2.91 Million	17,500 Added 243.06%	24,700 $2.89 Million
Q2 2021 Aug 06, 2021	BUY	$141.6 - $179.06 $1.02 Million - $1.29 Million	7,200 New	7,200 $1.19 Million
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $614,496 - $1.08 Million	-17,300 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $612,939 - $973,817	17,300 New	17,300 $661,000
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $951,601 - $1.21 Million	-13,700 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $98,910 - $139,965	1,500 Added 12.3%	13,700 $946,000
Q3 2017 Nov 15, 2017	BUY	$80.87 - $91.08 $986,614 - $1.11 Million	12,200	12,200 $1.11 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.